<!doctype html> <html> <head><style>
             table { border-collapse: collapse; }
             th, td {
               word-wrap: break-word;
               max-width: 100%;
               font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
               border-bottom: 1px solid #ddd;
               padding: 5px;
               text-align: left;
             }
            tr:hover {background: #f4f4f4;}
            tr:hover .highlighted {background: repeating-linear-gradient(
                    45deg,
                    #ffff99,
                    #ffff99 10px,
                    #f4f4f4 10px,
                    #f4f4f4 20px
                  );}
           .highlighted { background-color: #ffff99; }
          </style></head><body><h2>Biotie Therapies</h2><br> <b>Section Title</b>: Product pipeline <br><b>Table Section Text</b>: <i> None </i> <br> <table>
<tr> <th colspan=1 rowspan=1 > Name </th><th colspan=1 rowspan=1 > Target indications </th><th colspan=1 rowspan=1 > Partner </th><th colspan=1 rowspan=1 > Status </th></tr>
<tr> <td colspan=1 rowspan=1 > Selincro (nalmefene) </td><td colspan=1 rowspan=1 > alcohol dependence </td><td colspan=1 rowspan=1 > Lundbeck </td><td colspan=1 rowspan=1 > EU marketing authorization received </td></tr>
<tr> <td class="highlighted"  colspan=1 rowspan=1 > Tozadenant SYN115 </td><td class="highlighted"  colspan=1 rowspan=1 > Parkinson's disease </td><td colspan=1 rowspan=1 > UCB </td><td colspan=1 rowspan=1 > Phase III clinical trials to start 2015 </td></tr>
<tr> <td colspan=1 rowspan=1 > VAP-1 antibody </td><td colspan=1 rowspan=1 > inflammatory diseases </td><td colspan=1 rowspan=1 >  </td><td colspan=1 rowspan=1 > Phase I clinical trials ready, seeking partner </td></tr>
<tr> <td colspan=1 rowspan=1 > SYN120 </td><td colspan=1 rowspan=1 > AD, cognitive disorders </td><td colspan=1 rowspan=1 >  </td><td colspan=1 rowspan=1 > Phase I clinical trials ready, seeking partner </td></tr>
<tr> <td colspan=1 rowspan=1 > Nepicastat SYN117 </td><td colspan=1 rowspan=1 > PTSD, cocaine dependency </td><td colspan=1 rowspan=1 > NIDA </td><td colspan=1 rowspan=1 > PTSD: Phase II clinical trials, results Cocaine dependency: Phase II clinical trials, in progress </td></tr>
<tr> <td colspan=1 rowspan=1 > Ronomilast </td><td colspan=1 rowspan=1 > COPD </td><td colspan=1 rowspan=1 >  </td><td colspan=1 rowspan=1 > Phase I clinical trials ready, seeking partner </td></tr>
<tr> <td colspan=1 rowspan=1 > Nitisinone SYN118 </td><td colspan=1 rowspan=1 > Movement disorder </td><td colspan=1 rowspan=1 > UCB </td><td colspan=1 rowspan=1 > Phase II clinical trials, terminated </td></tr>
<tr> <td colspan=5 rowspan=1 > Sources: </td></tr>
</table> <br> <h3>Sentence(s)</h3>1. Tozadenant SYN115 is developed for Parkinson's disease. <br> <br><br><b>Categories:</b><br><b>Numerical:</b> Uses math skills for writing the sentence. Uses math operations (addition, subtraction, average, etc.), counting numbers, frequency of items, etc.<br> <b>Commonsense:</b> Uses commonsene knowledge about situations humans encounter in everyday life â€“ physical objects, word meanings, social or physical domains, peoples' intentions, etc.<br> <b>Temporal:</b> When concepts related to time and temporal aspects are required for writing the sentence. Duration, ordering, typical time of events, time differences between events.<br> <b>Table:</b> Writing the sentence requires knowledge from the table except: the highlighted cells, row and column headers, table titles, section titles, section texts.<br> <b>Out of Table:</b> Writing the sentence requires external knowledge that is not present in the table nor common sense. Knowledge about some specific domain comes under this category. </body></html>
